 | ||||||
| "anti diabetes" | ||||||
| WEB | ||||||
| Poxels Novel Anti diabetic Agent Imeglimin Meets Glycemic Endpoints in Phase 2b Dose Ranging ... ... Pharma: Efpeglenatide (GLP-1 Analog), The Promising Potential For Anti-Diabetes/Anti-Obesity Treatment As Once Weekly Up To Once Monthly.
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.